Neurocentre Magendie - U1215: Dépôts récents
Voici les éléments 1-20 de 387
-
Olfactory bulb astrocytes link social transmission of stress to cognitive adaptation in male mice
(Nature Communications. vol. 15, n° 1, 2024-08-18)Article de revueLibre accès -
A database of videos of physical exercise and sedentary behaviours to investigate automatic processes and perceptions related to physical exercise
(International Journal of Methods in Psychiatric Research. vol. 33, n° 2, 2024-06)Article de revueLibre accès -
Sex-based differences in growth-related IGF1 signaling in response to PAPP-A2 deficiency: comparative effects of rhGH, rhIGF1 and rhPAPP-A2 treatments
(Biology of Sex Differences. vol. 15, n° 1, pp. 34, 2024-04-08)Article de revueLibre accès -
ENSEMBLE PLUS: final results of shorter ocrelizumab infusion from a randomized controlled trial
(Journal of Neurology. vol. 271, n° 7, pp. 4348 – 4360, 2024-07)Article de revueLibre accès -
Cannabinoid type 2 receptor inhibition enhances the antidepressant and proneurogenic effects of physical exercise after chronic stress
(Translational Psychiatry. vol. 14, n° 1, pp. 170, 2024-03-30)Article de revueLibre accès -
A roadmap towards standardized neuroimaging approaches for human thalamic nuclei
(Nature Reviews Neuroscience. vol. 25, n° 12, pp. 792 – 808, 2024-12)Article de revueLibre accès -
The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls
(EMBO Molecular Medicine. vol. 16, n° 4, pp. 755 – 783, 2024-04)Article de revueLibre accès -
Planar cell polarity proteins mediate ketamine-induced restoration of glutamatergic synapses in prefrontal cortical neurons in a mouse model for chronic stress
(Nature Communications. vol. 15, n° 1, 2024-06-10)Article de revueLibre accès -
Translational models of stress and resilience: An applied neuroscience methodology review
(Neuroscience Applied. vol. 3, 2024-01)Article de revueLibre accès -
Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis: The Phase IIIb ENSEMBLE 4-Year, Single-Arm, Open-Label Trial
(Neurology. vol. 103, n° 12, 2024-12-24)Article de revueLibre accès -
Disease-modifying treatment and disability progression in subclasses of patients with primary progressive MS: results from the Big MS Data Network.
(Journal of Neurology, Neurosurgery and Psychiatry. vol. 96, n° 6, pp. 606-615, 2025-05-14)Article de revueDemander une copie -
Deep learning disconnectomes to accelerate and improve long-Term predictions for post-stroke symptoms
(Brain Communications. vol. 6, n° 5, 2024-09-30)Article de revueLibre accès -
Case report: Complete restoration of the HPA axis function in Cushing’s disease with drug treatment
(Frontiers in Endocrinology. vol. 15, 2024-02-08)Article de revueLibre accès -
In vivo bioluminescence imaging of the intracerebral fibroin-controlled AAV-α-synuclein diffusion for monitoring the central nervous system and peripheral expression
(Scientific Reports. vol. 14, n° 1, 2024-04-27)Article de revueLibre accès -
Advances in steroid research from the pioneering neurosteroid concept to metabolomics: New insights into pregnenolone function
(Frontiers in Neuroendocrinology. vol. 72, 2024-01)Article de revueLibre accès -
What influences food choices in anorexia nervosa? Disentangling cognitive and emotional components of decision-making by translational research
(Neuroscience Applied. vol. 3, 2024)Article de revueLibre accès -
Semaglutide Treatment in a Patient with Extreme Obesity and Massive Lymphedema: A Case Report
(Obesity Facts. vol. 17, n° 6, pp. 641 – 645, 2024)Article de revueLibre accès -
Autoimmune inflammation triggers aberrant astrocytic calcium signaling to impair synaptic plasticity
(Brain, Behavior, and Immunity. vol. 121, pp. 192 – 210, 2024-10)Article de revueLibre accès -
Classical psychedelics’ action on brain monoaminergic systems
(International Journal of Biochemistry and Cell Biology. vol. 176, 2024-11)Article de revue -
A sympathetic brake on gut GLP-1 release
(Neuron. vol. 112, n° 6, pp. 865 – 867, 2024-03-20)Article de revue